Turning Point Therapeutics, Inc. TPTX
Set alert
75.49 0.00 0.00%
At close · Aug 15
75.30 Day range 75.77
52-week range unavailable
- Open
- 75.32
- Prev close
- 75.49
- Mkt cap
- 3.81B
- Vol
- 1.03M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 75.30
- High
- 75.77
- Forward P/E
- -10.54
- Beta
- -0.19
- Short ratio
- 1.89
- Inst. own
- 92.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2022
- 50-d avg
- 75.21
- 200-d avg
- 46.90
- 1y target
- 71.50
Valuation
P/E -8.2×
FY 2017 5y median -20.8× FY 2021
P/S 63.2×
FY 2017 5y median 0.0× FY 2021
P/B 2.0×
FY 2017 5y median 3.7× FY 2021
P/FCF -12.5×
FY 2017 5y median -25.3× FY 2021
EV/EBITDA -6.6×
FY 2017 5y median -20.7× FY 2021
EV/Sales 49.5×
FY 2017 5y median 0.0× FY 2021
FCF Yield -8.0%
FY 2017 5y median -4.0% FY 2021
Profitability
Gross Margin 100.0%
FY 2017 5y median 0.0% FY 2021
Operating Margin -767.3%
FY 2017 5y median 0.0% FY 2021
Net Margin -767.3%
FY 2017 5y median 0.0% FY 2021
ROE -24.8%
FY 2017 5y median -17.8% FY 2021
ROIC -24.6%
FY 2017 5y median -24.6% FY 2021
ROA -23.6%
FY 2017 5y median -23.6% FY 2021
Growth (YoY)
Revenue 23.3%
FY 2017 FY 2021
Operating Income -46.2%
FY 2017 FY 2021
EPS (diluted) -50.4%
FY 2017 FY 2021
Free Cash Flow -86.0%
FY 2017 FY 2021
Financial Health
Current Ratio 21.1×
FY 2017 5y median 21.1× FY 2021
Quick Ratio 21.1×
FY 2017 5y median 21.1× FY 2021
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2021
Net Debt / EBITDA 1.8×
FY 2017 5y median 2.7× FY 2021
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2021
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2021
Annual · latest fiscal year ends 2021-12-31